Is Ambrx Biopharma Inc. (AMAM) a Buy, Sell, or Hold?
NYSE : AMAM
Ambrx Biopharma Inc.
$28 USD
$0.02 (0.07%)
- Volume
- 1.42M
- Average Volume
- 2M
- Market Capitalization
- $1.77B
- P/E Ratio
- -13.86
- Dividend Yield
- 0.00%
- Price Target
- Year High
- $28.15
- Year Low
- $6.55
- Day High
- —
- Day Low
- —
- Payout Ratio
- $0.00
- Current Ratio
- $5.44
Company Overview
NYSE
Daniel J. O'Connor
Biotechnology
Healthcare
AMAM
87
US
USD
Liquidity Metrics
0.10
5.44
5.21
3.34
0.00
Sales & Valuation
$7.4M
239.41
9.17
-25.41
-1.81
Profitability
-$2.02
-$78M
-1053.72%
-1027.55%
-50.68%
-53.07%
P/E Metrics
-13.86
-0.19
-0.19
Analyst Price Target & Rating
0/5
6 Analysts
%
Financial Health Scores
34.87
2/9
$215.55M
$271.5M
$29.1M
-$69.28M
Key Metrics (TTM)
$1.73B
233.51
-27.36
5.44
-50.68%
-43.23%
-7.22%
-3.93%
101 days
Company Executives
| Name | Title |
|---|---|
| Sonja Nelson | Chief Financial Officer |
| Daniel J. O'Connor | Chief Executive Officer, President & Director |
| Shawn Shao-Hui Zhang | Chief Scientific Officer & GM of China |
| Andrew Aromando | Chief Operating Officer |
| Robert Azzara | Vice President of Human Capital |
| Renu Vaish | Chief Regulatory Officer |
| Sandra Aung | Chief Clinical Officer |
| Ying J. Buechler | Chief Technology Officer |
| Jared Kelly | Senior Vice President, General Counsel & Corporate Secretary |
Poll Results
No votes yet today — be the first to share your view!
About Ambrx Biopharma Inc. (NYSE:AMAM) Stock
Ambrx Biopharma Inc. operates as a clinical-stage biotechnology company focused on the discovery and development of precisely engineered biologic medicines. The firm utilizes its unique expanded genetic code technology platform to create these advanced therapies. Leading its pipeline is ARX788, an anti-HER2 antibody-drug conjugate (ADC), which is currently undergoing evaluation in several clinical investigations. These include pivotal Phase 2/3 trials for the treatment of HER2-positive metastatic breast cancer and gastric cancer, alongside studies for other solid tumors. Additionally, Ambrx is progressing two earlier-stage drug candidates: ARX517, an anti-PSMA ADC, which is in a Phase 1 clinical trial for prostate cancer and other solid tumor indications; and ARX305, an anti-CD70 ADC, curr ... ently in investigational new drug (IND)-enabling studies for potential applications in renal cell carcinoma and other cancers. The company's portfolio also encompasses multiple immuno-oncology programs. Among these are ARX822, a fab-small molecule bispecific therapeutic in preclinical development for various cancers, and ARX102, an immuno-oncology IL-2 pathway agonist intended to stimulate the patient's immune system by targeting beta and gamma receptors on cytotoxic T cells. Founded in 2003 and headquartered in La Jolla, California, Ambrx Biopharma Inc. has established significant collaborations with various pharmaceutical partners, including Bristol Myers Squibb Company, AbbVie Inc., BeiGene, Sino Biopharmaceutical Co., Ltd., NovoCodex, and Elanco Animal Health.
Frequently Asked Questions
-
What is the current Ambrx Biopharma Inc. (AMAM) stock price?
-
Ambrx Biopharma Inc.(NYSE:AMAM) stock price is $28 in the last trading session. During the trading session, AMAM stock reached the peak price of $28.15 while $6.55 was the lowest point it dropped to. The percentage change in AMAM stock occurred in the recent session was 0.07% while the dollar amount for the price change in AMAM stock was $0.02.
-
AMAM's industry and sector of operation?
-
The NYSE listed AMAM is part of Biotechnology industry that operates in the broader Healthcare sector.
-
Who are the executives of AMAM?
-
Sonja Nelson | Chief Financial Officer
Daniel J. O'Connor | Chief Executive Officer, President & Director
Shawn Shao-Hui Zhang | Chief Scientific Officer & GM of China
Andrew Aromando | Chief Operating Officer
Robert Azzara | Vice President of Human Capital -
How many employees does AMAM have?
-
Number of AMAM employees currently stands at 87. AMAM operates from 10975 North Torrey Pines Road, La Jolla, CA 92037, US.
-
Link for AMAM official website?
-
Official Website of AMAM is: https://ambrx.com
-
How do I contact AMAM?
-
AMAM could be contacted at phone #858 875 2400 and can also be accessed through its website. AMAM operates from 10975 North Torrey Pines Road, La Jolla, CA 92037, US.
-
How many shares of AMAM are traded daily?
-
The average number of AMAM shares traded daily for last 3 months was 2M.
-
What is the market cap of AMAM currently?
-
The market value of AMAM currently stands at $1.77B with its latest stock price at $28